Physician Perceptions of the Safety and Efficacy of GLP-1 Receptor Agonists: Underestimation of Cardiovascular Risk Reduction and Discrepancies with Clinical Evidence
Related Posts
Taha A, Mondal A, Sandhyavenu H, Atti L, Alhajji M, Thangjui S, Shaik BF, Thyagaturu H, Caccamo M, Fonarow GC, Balla S. Outcomes of Early[...]
Nouh A, Olson D, Liang H, Koriesh A, Ali M, Bashir MMI, Mukerjee P, Man S, Fonarow GC. In-Hospital Stroke Quality and Outcomes in the[...]
Ahmed M, Hashmi TM, Shahzad M, Zia R, Ashraf H, Ahmed R, Rashid M, Greene SJ, Mentz RJ, Fudim M, Fonarow GC, Rana JS. Cardiovascular[...]